Junyi Zhen

Title: Innovations by Junyi Zhen in Tumor Detection

Introduction

Junyi Zhen is an accomplished inventor based in Beijing, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of tumors. With a total of two patents to his name, Zhen's work focuses on innovative reagent compositions that enhance the accuracy of tumor detection.

Latest Patents

Zhen's latest patents include a reagent composition for the detection of non-hematopoietic tumors. This invention provides a comprehensive set of antibodies designed for flow cytometry screening, diagnosis, and follow-up detection of such tumors. The reagent composition consists of three sets of antibodies, each targeting specific markers associated with non-hematopoietic tumors.

Another notable patent by Zhen is a detection reagent and therapeutic target for B cell tumors following targeted therapy. This invention also comprises three groups of antibodies, which are utilized for the detection of B-lymphocyte tumors through flow cytometry. Both patents reflect Zhen's commitment to advancing cancer diagnostics and improving patient outcomes.

Career Highlights

Throughout his career, Junyi Zhen has worked with reputable organizations, including Synarc Research Laboratory and Hebei Yanda Ludaopei Hospital. His experience in these institutions has allowed him to collaborate with other professionals in the field, further enhancing his expertise in medical research and diagnostics.

Collaborations

Zhen has collaborated with notable coworkers such as Hui Wang and Man Chen. These partnerships have contributed to the development of his innovative patents and have fostered a collaborative environment for research and discovery.

Conclusion

Junyi Zhen's contributions to tumor detection through his innovative patents demonstrate his dedication to improving medical diagnostics. His work not only advances scientific knowledge but also has the potential to significantly impact patient care in oncology.